Paper Details

Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study

Fereshteh Ashtari

Fereshteh Ashtari

Professor of Neurology

Department of Neurology, School of Medicine

Neurosciences Research Center

Kashani Hospital

Isfahan University of Medical Sciences

Related Documents

1. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)

2. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)

3. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)

4. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)

5. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)

6. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)

7. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)

8. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)

9. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)

10. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)

11. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

12. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)

13. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)

14. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)

15. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)

16. Estimated Incidence Rate of Multiple Sclerosis and Its Relationship With Geographical Factors in Isfahan Province Between the Years 2001 and 2014, International Journal of Preventive Medicine (2018)

17. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)

18. Reciprocal Effects of Multiple Sclerosis, Childbirth, and Postpartum, Iranian Journal of Neonatology (2018)

19. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)

20. Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases, Journal of Central Nervous System Disease (2024)

21. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)

22. Thalamic Asymmetry in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)

23. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)

24. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)

25. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)

26. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)

27. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)

28. Co-Occurrence of Multiple Sclerosis and Thomsen’S Myotonia: A Report of Two Cases, Functional Neurology (2014)

29. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)

30. Side Effects of Methylprednisolone Pulse Therapy in Treatment of Multiple Sclerosis, Journal of Isfahan Medical School (2012)

31. Cognitive Function and Brain Magnetic Resonance Imaging Profiles in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis, Journal of Research in Medical Sciences (2024)

32. Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study, Pakistan Journal of Medical Sciences (2012)

33. Chlamydia Pneumoniae Seropositivity in Iranian Patients With Multiple Sclerosis: A Pilot Study; [Obecnosc Przeciwcial Przeciw Chlamydia Pneumoniae Wsrod Iranskich Chorych Na Stwardnienie Rozsiane: Badanie Pilotazowe], Neurologia i Neurochirurgia Polska (2011)

34. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)

35. Naming Error in Multiple Sclerosis Patients: A Pilot Study in Isfahan, Iran, Journal of Research in Medical Sciences (2019)

36. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)

37. Short-Term Safety of Pulse Steroid Therapy in Multiple Sclerosis Relapses, Clinical Neuropharmacology (2013)

38. Prevalence of Sexual Dysfunction and Related Risk Factors in Men With Multiple Sclerosis in Iran: A Multicenter Study, Neurology and Therapy (2021)

39. Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors, Journal of Research in Medical Sciences (2014)

40. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)

41. Seizure Characteristics in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)

42. Psychological Well-Being in People With Multiple Sclerosis in an Iranian Population, Journal of Research in Medical Sciences (2015)

43. Adverse Reaction of Methylprednisolone Pulse Therapy: Acute Respiratory Distress Syndrome, Clinical Case Reports (2021)

44. An 8-Year Study of People With Multiple Sclerosis in Isfahan, Iran: Association Between Environmental Air Pollutants and Severity of Disease, Journal of Neuroimmunology (2018)

45. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)

46. The Relationship Between the Amount of Radiation, Relative Humidity, and Temperature With the Risk of Multiple Sclerosis in Isfahan Province, Iran, During the Years 2001-2014, Journal of Isfahan Medical School (2017)

47. Cow's Milk Allergy in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)

48. Neuromyelitis Optica Spectrum Disease Characteristics in Isfahan, Iran: A Cross-Sectional Study, Journal of Research in Medical Sciences (2017)

49. Study of Type a and B Behavior Patterns in Patients With Multiple Sclerosis in an Iranian Population, International Journal of Preventive Medicine (2013)

50. Does Amantadine Have Favourable Effects on Fatigue in Persian Patients Suffering From Multiple Sclerosis?, Neurologia i Neurochirurgia Polska (2009)

51. Effects of Low Dose Methotrexate on Relapsing-Remitting Multiple Sclerosis in Comparison to Interferon Β-1Α: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2011)

All Documents

1. Association of Peripapillary Retinal Nerve Fiber Layer Atrophy With Cognitive Impairment in Patients With Neuromyelitis Optica Spectrum Disorder, Neurological Sciences (2025)

2. Investigating Treatment Alternatives for Fingolimod in Patients With Multiple Sclerosis Developed Refractory Fingolimod-Related Genital Human Papilloma Virus (Hpv) Infection, Multiple Sclerosis and Related Disorders (2025)

3. Relationship Between Sleep Disorders and Information Processing Speed in Multiple Sclerosis, Clinics (2025)

4. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)

5. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)

6. Cognitive Function and Brain Magnetic Resonance Imaging Profiles in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis, Journal of Research in Medical Sciences (2024)

7. Comparing the Effects of Smartphone-Based and Face-To-Face Education on the Quality of Life and Coping Skills Among Patients With Multiple Sclerosis: A Randomized Controlled Trial, Journal of Education and Health Promotion (2024)

8. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)

9. Deep Learning and Classic Machine Learning Models in the Automatic Diagnosis of Multiple Sclerosis Using Retinal Vessels, Multimedia Tools and Applications (2024)

10. Diagnosis of Multiple Sclerosis by Detecting Asymmetry Within the Retina Using a Similarity-Based Neural Network, IEEE Access (2024)

11. Discrimination of Multiple Sclerosis Using Scanning Laser Ophthalmoscopy Images With Autoencoder-Based Feature Extraction, Multiple Sclerosis and Related Disorders (2024)

12. Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases, Journal of Central Nervous System Disease (2024)

13. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)

14. Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis: A Phase Iii, Randomized, Equivalency, Clinical Trial, Scientific Reports (2024)

15. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)

16. Investigation of the Effects of Cocoa Powder on Fatigue Severity in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Clinical Nutrition Open Science (2024)

17. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)

18. Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders, Neurology: Neuroimmunology and NeuroInflammation (2024)

19. Slo-Net: Enhancing Multiple Sclerosis Diagnosis Beyond Optical Coherence Tomography Using Infrared Reflectance Scanning Laser Ophthalmoscopy Images, Translational Vision Science and Technology (2024)

20. The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic, Multiple Sclerosis and Related Disorders (2024)

21. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)

22. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)

23. A Mechanistic Insight Into Sources of Error of Visual Working Memory in Multiple Sclerosis, eLife (2023)

24. Assessment of Intelligence Quotient in Patients With Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)

25. Comparative Analysis of Apigenin-3 Acetate Versus Apigenin and Methyl-Prednisolone in Inhibiting Proliferation and Gene Expression of Th1 Cells in Multiple Sclerosis, Cell Journal (2023)

26. Diagnostic Value of Intereye Difference Metrics for Optic Neuritis in Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders, Journal of Neurology, Neurosurgery and Psychiatry (2023)

27. Discrimination of Multiple Sclerosis Using Oct Images From Two Different Centers, Multiple Sclerosis and Related Disorders (2023)

28. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)

29. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)

30. Effect of Deep Gray Matter Atrophy on Information Processing Speed in Early Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)

31. Epidemiologic and Clinical Characteristics of Neuromyelitis Optica Spectrum Disorder Patients, a Seven Years Follow-Up Study From Iran, Multiple Sclerosis and Related Disorders (2023)

32. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)

33. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)

34. Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis, Scientific Reports (2023)

35. Pemphigus Vulgaris in a Patient With Multiple Sclerosis: A Case Report With 7 Years of Follow Up, Journal of Research in Dental and Maxillofacial Sciences (2023)

36. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)

37. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)

38. Thalamic Asymmetry in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)

39. Working Memory Dysfunction Differs Between Secondary Progressive and Relapsing Multiple Sclerosis: Effects of Clinical Phenotype, Age, Disease Duration, and Disability, Multiple Sclerosis and Related Disorders (2023)

40. Astrocytic Outer Retinal Layer Thinning Is Not a Feature in Aqp4-Igg Seropositive Neuromyelitis Optica Spectrum Disorders, Journal of Neurology, Neurosurgery and Psychiatry (2022)

41. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

42. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

43. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)

44. Covid-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran, Vaccines (2022)

45. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)

46. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)

47. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)

48. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)

49. Prevalence and Characteristics of Ponticulus Posticus and Its Association With Cervicogenic Headache and Migraine: A Lateral Cephalometric Study, Journal of Research in Medical Sciences (2022)

50. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)

51. Serum Levels of Interleukin-6 and Vitamin D at the Onset of Multiple Sclerosis and Neuromyelitis Optica: A Pilot Study, Journal of Research in Medical Sciences (2022)

52. Synthetic Oct Data Generation to Enhance the Performance of Diagnostic Models for Neurodegenerative Diseases, Translational Vision Science and Technology (2022)

53. The Impact of Covid-19 Pandemic on Neuromyelitis Optica Disorder Patients, After One Year, Caspian Journal of Neurological Sciences (2022)

54. Adverse Reaction of Methylprednisolone Pulse Therapy: Acute Respiratory Distress Syndrome, Clinical Case Reports (2021)

55. Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Population-Based Study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625, Multiple sclerosis and related disorders (2021)

56. Depression, Anxiety, and Stress Relative to Swallowing Impairment in Persons With Multiple Sclerosis, Dysphagia (2021)

57. Effect of Auricular Acupuncture With Semi-Permanent Ear Needles on Controlling Migraine Symptoms: A Single-Blind Randomized Clinical Trial, JAMS Journal of Acupuncture and Meridian Studies (2021)

58. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)

59. Fear and Anxiety in Patients With Multiple Sclerosis During Covid-19 Pandemic; Report of an Iranian Population, Multiple Sclerosis and Related Disorders (2021)

60. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)

61. Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Population-Based Study, Multiple Sclerosis and Related Disorders (2021)

62. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)

63. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)

64. Prevalence of Sexual Dysfunction and Related Risk Factors in Men With Multiple Sclerosis in Iran: A Multicenter Study, Neurology and Therapy (2021)

65. Prevalence of Sexual Dysfunction and Related Risk Factors in Men With Multiple Sclerosis in Iran: A Multicenter Study, Neurology and Therapy (2021)

66. Research Paper: Anti-Myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Neurological Sciences (2021)

67. Retinal Oct Texture Analysis for Differentiating Healthy Controls From Multiple Sclerosis (Ms) With/Without Optic Neuritis, BioMed Research International (2021)

68. Retinal Optical Coherence Tomography in Neuromyelitis Optica, Neurology: Neuroimmunology and NeuroInflammation (2021)

69. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)

70. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)

71. Cohort Profile: A Collaborative Multicentre Study of Retinal Optical Coherence Tomography in 539 Patients With Neuromyelitis Optica Spectrum Disorders (Croctino), BMJ Open (2020)

72. Cohort Profile: A Collaborative Multicentre Study of Retinal Optical Coherence Tomography in 539 Patients With Neuromyelitis Optica Spectrum Disorders (Croctino), BMJ Open (2020)

73. Pre-Pregnancy, Obstetric and Delivery Status in Women With Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2020)

74. Rituximab Associated Necrosis: A Case Report, Multiple Sclerosis and Related Disorders (2020)

75. Tumefactive Rebound of Multiple Sclerosis After the Short-Term Cessation of Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2020)

76. Tumefactive Rebound of Multiple Sclerosis After the Short-Term Cessation of Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2020)

77. Disease Course, Progression and Activity of Neuromyelitis Optica (Nmosd) in Patients Who Were Treated With Rituximab, 6 and 12 Months After Receiving the First Dose of Drug, in Isfahan City, Multiple Sclerosis and Related Disorders (2019)

78. Long-Term Tolerability, Safety and Efficacy of Rituximab in Neuromyelitis Optica Spectrum Disorder: A Prospective Study, Journal of Neurology (2019)

79. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)

80. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)

81. Naming Error in Multiple Sclerosis Patients: A Pilot Study in Isfahan, Iran, Journal of Research in Medical Sciences (2019)

82. Niemann-Pick Diseases: The Largest Iranian Cohort With Genetic Analysis, Iranian Journal of Child Neurology (2019)

83. An 8-Year Study of People With Multiple Sclerosis in Isfahan, Iran: Association Between Environmental Air Pollutants and Severity of Disease, Journal of Neuroimmunology (2018)

84. Cerebral Phaeohyphomycosis Due to Rhinocladiella Mackenziei in Persian Gulf Region: A Case and Review, Mycoses (2018)

85. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)

86. Estimated Incidence Rate of Multiple Sclerosis and Its Relationship With Geographical Factors in Isfahan Province Between the Years 2001 and 2014, International Journal of Preventive Medicine (2018)

87. Neuromyelitis Optica Spectrum Disorder and Menstruation, Revue Neurologique (2018)

88. Neutralizing Antibody Production Against Rebif® and Recigen® in Relapsing-Remitting Multiple Sclerosis (Rrms) Patients and Its Association With Patient's Disability, International Immunopharmacology (2018)

89. Neutralizing Antibody Production Against Rebif® and Recigen® in Relapsing-Remitting Multiple Sclerosis (Rrms) Patients and Its Association With Patient's Disability, International Immunopharmacology (2018)

90. Patient Preferences for Interferon-Beta in Iran: A Discrete Choice Experiment, PLoS ONE (2018)

91. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)

92. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)

93. Reciprocal Effects of Multiple Sclerosis, Childbirth, and Postpartum, Iranian Journal of Neonatology (2018)

94. The Effect of Auriculotherapy on Stress, Anxiety, and Depression in Ms Patients: A Double Blind Randomized Clinical Control Trial (Parallel Design), Acta Medica Mediterranea (2018)

95. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)

96. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)

97. Comparison of the Efficacy of Azathioprine and Rituximab in Neuromyelitis Optica Spectrum Disorder: A Randomized Clinical Trial, Journal of Neurology (2017)

98. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)

99. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)

100. Effect of Extracorporeal Shock Wave Therapy on Lower Limb Spasticity in Stroke Patients, Archives of Iranian Medicine (2017)

101. Neuromyelitis Optica Spectrum Disease Characteristics in Isfahan, Iran: A Cross-Sectional Study, Journal of Research in Medical Sciences (2017)

102. The Relationship Between the Amount of Radiation, Relative Humidity, and Temperature With the Risk of Multiple Sclerosis in Isfahan Province, Iran, During the Years 2001-2014, Journal of Isfahan Medical School (2017)

103. High Dose Vitamin D Intake and Quality of Life in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Neurological Research (2016)

104. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)

105. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)

106. Prevalence, Severity of Pain in Patients With Multiple Sclerosis (Ms), Biomedical and Pharmacology Journal (2016)

107. Effect of High Dose Vitamin D Intake on Interleukin-17 Levels in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Neuroimmunology (2015)

108. Psychological Well-Being in People With Multiple Sclerosis in an Iranian Population, Journal of Research in Medical Sciences (2015)

109. Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, NeuroImmunoModulation (2015)

110. Co-Occurrence of Multiple Sclerosis and Thomsen’S Myotonia: A Report of Two Cases, Functional Neurology (2014)

111. Correlation of Midkine Serum Level With Pro- and Anti-Inflamatory Cytokines in Multiple Sclerosis, Iranian Journal of Immunology (2014)

112. Islamic Fasting and Multiple Sclerosis, BMC Neurology (2014)

113. Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors, Journal of Research in Medical Sciences (2014)

114. Validation of the Persian Translation of the Swallowing Disturbance Questionnaire in Parkinson's Disease Patients, Parkinson's Disease (2014)

115. Analysis of the Ctage5 P521a Variation With the Risk of Familial Idiopathic Basal Ganglia Calcification in an Iranian Population, Journal of Molecular Neuroscience (2013)

116. Convulsive Syncope As Presenting Symptom of Carotid Body Tumors: Case Series, Journal of Research in Medical Sciences (2013)

117. Cow's Milk Allergy in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)

118. Mutation Analysis of Slc20a2 and Spp2 As Candidate Genes for Familial Idiopathic Basal Ganglia Calcification, Avicenna Journal of Medical Biotechnology (2013)

119. Seizure Characteristics in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)

120. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)

121. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)

122. Short-Term Safety of Pulse Steroid Therapy in Multiple Sclerosis Relapses, Clinical Neuropharmacology (2013)

123. Speed of Word Retrieval in Multiple Sclerosis, Journal of Research in Medical Sciences (2013)

124. Study of Type a and B Behavior Patterns in Patients With Multiple Sclerosis in an Iranian Population, International Journal of Preventive Medicine (2013)

125. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)

126. The Relation Between Vitamin D Status With Fatigue and Depressive Symptoms of Multiple Sclerosis, Journal of Research in Medical Sciences (2013)

127. Color Blindness Among Multiple Sclerosis Patients in Isfahan, Journal of Research in Medical Sciences (2012)

128. Combination Therapy With Mitoxantrone and Plasma Exchange in Aggressive Relapsing Remitting Multiple Sclerosis: A Preliminary Clinical Study, Journal of Research in Medical Sciences (2012)

129. Comparison of the Effect of Aspirin and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Blinded, Crossover Study, Neurological Research (2012)

130. Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study, Pakistan Journal of Medical Sciences (2012)

131. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)

132. Metabolic Syndrome in Ischemic Stroke: A Case Control Study, Journal of Research in Medical Sciences (2012)

133. Side Effects of Methylprednisolone Pulse Therapy in Treatment of Multiple Sclerosis, Journal of Isfahan Medical School (2012)

134. Chlamydia Pneumoniae Seropositivity in Iranian Patients With Multiple Sclerosis: A Pilot Study; [Obecnosc Przeciwcial Przeciw Chlamydia Pneumoniae Wsrod Iranskich Chorych Na Stwardnienie Rozsiane: Badanie Pilotazowe], Neurologia i Neurochirurgia Polska (2011)

135. Clinical and Paraclinical Findings in Admitted Patients in Epilepsy Ward, Journal of Isfahan Medical School (2011)

136. Effects of Low Dose Methotrexate on Relapsing-Remitting Multiple Sclerosis in Comparison to Interferon Β-1Α: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2011)

137. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)

138. A Case of Wolfram Syndrome, Journal of Ophthalmic and Vision Research (2010)

139. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)

140. Effects of Adjunct Glucosamine Sulfate on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized, Placebo-Controlled Trial, Neurological Research (2010)

141. Fahr's Disease: Variable Presentations in a Family, Neurological Sciences (2010)

142. The Assessment Value of Transcranial Doppler Sonography Versus Magnetic Resonance Angiography in Vertebrobasilar Stroke, Journal of Research in Medical Sciences (2010)

143. Devic's Syndrome Concomitant With Nephritis in a Young Woman, Clinical Rheumatology (2009)

144. Does Amantadine Have Favourable Effects on Fatigue in Persian Patients Suffering From Multiple Sclerosis?, Neurologia i Neurochirurgia Polska (2009)

145. Sensory Complaints of the Upper Extremities in Multiple Sclerosis: Relative Efficacy of Nortriptyline and Transcutaneous Electrical Nerve Stimulation, Clinical Journal of Pain (2009)

146. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)

147. A Double-Blind, Randomized Trial of Low-Dose Topiramate Vs Propranolol in Migraine Prophylaxis, Acta Neurologica Scandinavica (2008)

148. Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis, Canadian Journal of Neurological Sciences (2008)

149. Relationship Between Helicobacter Pylori Immunoglobulin G Antibody and Thrombotic Ischemic Stroke, Acta Medica Iranica (2008)

150. The Correlation of Nitrate Concentration With Lesion Size in Initial Phase of Stroke; It Is Not Correlated With National Institute Health Stroke Scale, Journal of Research in Medical Sciences (2008)

151. Association Between Chlamydia Pneumoniae Infection and Carotid Atherosclerotic Plaques, Journal of Research in Medical Sciences (2007)

152. Chlamydia Pneumoniae Infection and Thrombotic Ischemic Stroke, Journal of Isfahan Medical School (2007)

153. A Randomized, Double-Blind Trial of Bromocriptine Efficacy in Nonfluent Aphasia After Stroke, Neurology (2006)

154. Comparison of the Effect of Topiramate and Sodium Valporate in Migraine Prevention: A Randomized Blinded Crossover Study, Headache (2006)

155. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)

156. A Study of the Relatioship Between Syncope Attacks and Diminished Carotid and Vetebral Artery Flow Using Doppler Ultrasonography of Cervical Vessels, Journal of Research in Medical Sciences (2005)

157. Duplex Ultrasonography of Carotid Arteries in Ischemic Stroke Patients and Control Group [2], Journal of Research in Medical Sciences (2005)

158. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)